Patents by Inventor Lisa Danzig

Lisa Danzig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210060151
    Abstract: Multivalent meningococcal conjugate vaccines are administered according to a schedule in which a first dose is administered to a patient aged between 0 and 12 months, and a second dose is administered to the patient aged between 12 and 24 months.
    Type: Application
    Filed: October 28, 2020
    Publication date: March 4, 2021
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventor: Lisa DANZIG
  • Patent number: 10881721
    Abstract: Multivalent meningococcal conjugate vaccines are administered according to a schedule in which a first dose is administered to a patient aged between 0 and 12 months, and a second dose is administered to the patient aged between 12 and 24 months.
    Type: Grant
    Filed: December 17, 2019
    Date of Patent: January 5, 2021
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventor: Lisa Danzig
  • Patent number: 10828361
    Abstract: Multivalent meningococcal conjugate vaccines are administered according to a schedule in which at least one or two doses are administered to a patient aged between 0 and 12 months, and a further dose is administered to a patient aged between 12 and 24 months.
    Type: Grant
    Filed: October 6, 2008
    Date of Patent: November 10, 2020
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventor: Lisa Danzig
  • Publication number: 20200138932
    Abstract: Multivalent meningococcal conjugate vaccines are administered according to a schedule in which a first dose is administered to a patient aged between 0 and 12 months, and a second dose is administered to the patient aged between 12 and 24 months.
    Type: Application
    Filed: December 17, 2019
    Publication date: May 7, 2020
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventor: Lisa DANZIG
  • Patent number: 10543265
    Abstract: Multivalent meningococcal conjugate vaccines are administered according to a schedule in which a first dose is administered to a patient aged between 0 and 12 months, and a second dose is administered to the patient aged between 12 and 24 months.
    Type: Grant
    Filed: March 22, 2007
    Date of Patent: January 28, 2020
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventor: Lisa Danzig
  • Publication number: 20090297553
    Abstract: Multivalent meningococcal conjugate vaccines are administered according to a schedule in which a first dose is administered to a patient aged between 0 and 12 months, and a second dose is administered to the patient aged between 12 and 24 months.
    Type: Application
    Filed: March 22, 2007
    Publication date: December 3, 2009
    Inventor: Lisa Danzig
  • Publication number: 20090098156
    Abstract: Multivalent meningococcal conjugate vaccines are administered according to a schedule in which at least one or two doses are administered to a patient aged between 0 and 12 months, and a further dose is administered to a patient aged between 12 and 24 months.
    Type: Application
    Filed: October 6, 2008
    Publication date: April 16, 2009
    Inventor: Lisa Danzig
  • Publication number: 20080026002
    Abstract: Multivalent meningococcal conjugate vaccines are administered according to a schedule in which a first dose is administered to a patient aged between 0 and 12 months, and a second dose is administered to the patient aged between 12 and 24 months.
    Type: Application
    Filed: March 22, 2007
    Publication date: January 31, 2008
    Inventor: Lisa Danzig